HBMK — Hubei Minkang Pharmaceutical Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Hubei Minkang Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 March 31st | 2010 March 31st | 2011 March 31st | 2012 December 31st | R2013 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-Q |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.004 | 0.007 | 0.001 | 6.07 | 6.23 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | 2.95 | 2.53 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.004 | 0.007 | 0.001 | 13.2 | 14.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.23 | 0.647 | 0 | 4.85 | 4.74 |
| Net Intangible Assets | |||||
| Total Assets | 2.23 | 0.655 | 0.001 | 20.5 | 21.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.65 | 1.82 | 0.432 | 9.54 | 10.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.65 | 1.82 | 0.432 | 9.54 | 10.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.579 | -1.17 | -0.431 | 11 | 11.4 |
| Total Liabilities & Shareholders' Equity | 2.23 | 0.655 | 0.001 | 20.5 | 21.6 |
| Total Common Shares Outstanding |